台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    154.5
  • 漲跌
    ▲4.5
  • 漲幅
    +3.00%
  • 成交量
    9
  • 產業
    上櫃 生技醫療類股
  • 68人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-元大-西屯 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-西屯 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/1800.000153.00153.00010-0.29%
2023/07/0500.001172.00172.00-151-1.94%
2023/06/130174.0000.00172.000530.06%
2023/05/262184.7500.00185.002613.23%
2023/05/251190.5000.00191.501611.62%
2023/05/0900.001182.50181.50-159-1.68%
2023/05/051182.0000.00182.001581.71%
2023/05/031181.0000.00183.501581.72%
2023/04/2100.002180.00180.00-249-4.08%
2023/04/1700.007182.29181.00-747-14.84%
2023/04/131174.503177.50177.50-244-4.50%
2023/03/2400.001168.00166.50-156-1.77%
2023/03/0700.005182.00177.50-560-8.22%
2023/03/0600.005182.00180.00-560-8.33%
2023/03/022171.7500.00173.002583.43%
2023/02/241166.001167.00166.000570.00%
2023/02/152161.7500.00160.002663.00%
2023/02/141160.5000.00160.501661.50%
2023/02/131156.0000.00156.001661.50%
2023/02/102157.7500.00157.002663.01%
2023/02/0800.005161.30160.00-566-7.51%
2023/01/0600.000163.50163.00069-0.03%
2022/12/130160.0000.00159.500610.03%
2022/11/015138.0000.00138.5051005.00%
2022/10/285136.0000.00134.0051004.95%
2022/10/242140.0000.00139.5021011.96%
2022/10/132146.0000.00143.0021041.92%
2022/09/271147.0000.00151.0011010.98%
2022/09/261152.0000.00147.0011010.98%
2022/09/202158.0000.00158.0021031.93%
2022/09/191158.0000.00157.0011020.98%
2022/09/151164.0000.00165.0011001.00%
2022/08/3000.005176.90175.50-591-5.45%
2022/08/245175.0000.00170.005845.90%
2022/08/181160.001161.00160.000740.00%
2022/08/1100.001151.00150.00-159-1.67%
2022/08/1000.007142.93146.00-756-12.44%
2022/07/293137.501134.00134.502494.01%
2022/07/070.1118.0000.00117.000.1480.22%
2022/06/0600.002132.00132.50-236-5.41%
2022/02/211129.5000.00129.501691.45%
2022/02/1600.001128.00128.50-166-1.50%
2022/02/1100.003125.50125.50-365-4.56%
2022/02/1000.002126.00127.50-265-3.04%
2022/02/075130.802130.00131.003624.80%
2021/12/0600.005108.40109.00-520-24.33%
2021/12/035109.7000.00109.0052024.49%
2021/11/2600.000.2105.44106.50-0.220-0.86%
2021/11/250.2102.0000.00105.500.2200.85%
2021/11/1700.000.1102.59104.50-0.121-0.45%
2021/11/160.1101.0000.00105.000.1210.46%
2021/09/2300.00289.4089.60-235-5.66%
2021/09/22285.8000.0090.302355.64%
2021/06/184106.7500.00107.0043710.55%
2021/06/151106.5000.00106.501382.59%
2021/04/2000.000114.00115.50052-0.01%
2021/04/190112.5000.00115.000530.01%
2021/02/0100.00098.5499.20050-0.06%
2021/01/29099.5000.0099.700500.06%
2019/09/0900.002143.50140.50-2113-1.76%
2019/07/292154.0000.00159.502862.32%
2019/04/1000.002118.50119.50-253-3.71%
2019/03/271114.5000.00116.001502.00%
2019/03/131122.0000.00122.501412.43%
2018/07/231122.0000.00121.0011180.85%
2018/04/2500.001167.00166.00-1371-0.27%
2018/01/161170.0000.00168.0012940.34%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章